Literature DB >> 31519326

Solid lipid nanoparticles as a drug delivery system to across the blood-brain barrier.

Haifei He1, Ju Yao2, Yingxin Zhang2, Yidan Chen3, Kaifeng Wang4, Robert J Lee5, Bo Yu6, Xiaomin Zhang7.   

Abstract

Solid lipid nanoparticles (SLNs) were prepared by biocompatible and biodegradable solid-phase lipids. β-elemene is a safe natural essential oil with broad-spectrum anti-tumor activity. However, its clinical application has been adversely affected by its poor water solubility and limited bioavailability. SLN incorporation is a potential strategy to bypass the blood-brain barrier, the most important factor limiting the bioactivity of neurotherapeutics. The SLNs-β has the same efficacy as commercially available elemene in vitro and an enhanced brain drug accumulation in vivo. The survival rate data was promising and acute toxicity experiment proved its safety. All these data suggested that SLN-β is a safe and effective drug delivery system, especially for brain tumor therapy, and warrants further development.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood-brain barrier; Glioma; Solid lipid nanoparticles; β-elemene

Mesh:

Substances:

Year:  2019        PMID: 31519326     DOI: 10.1016/j.bbrc.2019.09.017

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Comparing cefotaxime and ceftriaxone in combating meningitis through nose-to-brain delivery using bio/chemoinformatics tools.

Authors:  Rania M Hathout; Sherihan G Abdelhamid; Ghadir S El-Housseiny; Abdelkader A Metwally
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379

Review 2.  Nanoparticle delivery systems for substance use disorder.

Authors:  Vishal Kasina; Robert J Mownn; Raman Bahal; Gregory C Sartor
Journal:  Neuropsychopharmacology       Date:  2022-03-28       Impact factor: 8.294

Review 3.  Perspectives and Prospective on Solid Lipid Nanoparticles as Drug Delivery Systems.

Authors:  Osama A Madkhali
Journal:  Molecules       Date:  2022-02-24       Impact factor: 4.411

4.  Trehalose-Based Nucleolipids as Nanocarriers for Autophagy Modulation: An In Vitro Study.

Authors:  Anthony Cunha; Alexandra Gaubert; Julien Verget; Marie-Laure Thiolat; Philippe Barthélémy; Laurent Latxague; Benjamin Dehay
Journal:  Pharmaceutics       Date:  2022-04-13       Impact factor: 6.525

5.  Novel Phenobarbital-Loaded Nanostructured Lipid Carriers for Epilepsy Treatment: From QbD to In Vivo Evaluation.

Authors:  Sebastian Scioli-Montoto; Maria Laura Sbaraglini; Jose Sebastian Cisneros; Cecilia Yamil Chain; Valeria Ferretti; Ignacio Esteban León; Vera Alejandra Alvarez; Guillermo Raul Castro; German Abel Islan; Alan Talevi; Maria Esperanza Ruiz
Journal:  Front Chem       Date:  2022-08-17       Impact factor: 5.545

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.